Mizuho analyst Gregg Moskowitz downgraded Rapid7 to Neutral from Buy with a price target of $45, down from $70. The company reported a “very mixed” Q3, with annual recurring revenue growth of 24% coming one point below the Street’s estimate, Moskowitz tells investors in a research note. The company also meaningfully lowered its Q4 outlook due to macro uncertainty, says the analyst. He expects Rapid7’s go-to-market challenges could persist for several quarters, which “could make it quite challenging for RPD to outperform.”